Compounds > edotreotide
Page last updated: 2024-09-04

edotreotide and Local Neoplasm Recurrence

edotreotide has been researched along with Local Neoplasm Recurrence in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishimori, T; Nakamoto, Y; Saji, H; Sano, K; Temma, T; Togashi, K; Ueda, M1
Baio, SM; Bodei, L; Colandrea, M; Fazio, N; Galetta, D; Gilardi, L; Grana, CM; Mariniello, A; Paganelli, G; Papi, S; Tinelli, C; Valmadre, G1
Aricò, D; Baio, SM; Bartolomei, M; Bodei, L; Botteri, E; Cremonesi, M; De Cicco, C; Grana, CM; Paganelli, G; Sansovini, M1
Debus, J; Haberkorn, U; Henze, M; Hoess, A; Huber, P; Milker-Zabel, S; Schulz-Ertner, D; Zabel-du Bois, A1

Trials

1 trial(s) available for edotreotide and Local Neoplasm Recurrence

ArticleYear
Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningioma.
    European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:9

    Topics: Adolescent; Adult; Aged; Child; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Young Adult; Yttrium Radioisotopes

2009

Other Studies

3 other study(ies) available for edotreotide and Local Neoplasm Recurrence

ArticleYear
Additional information gained by positron emission tomography with (68)Ga-DOTATOC for suspected unknown primary or recurrent neuroendocrine tumors.
    Annals of nuclear medicine, 2015, Volume: 29, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Female; Gallium Radioisotopes; Hormones; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed

2015
Long-term results of PRRT in advanced bronchopulmonary carcinoid.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:3

    Topics: Aged; Carcinoid Tumor; Carcinoma, Neuroendocrine; Cohort Studies; Creatinine; Data Collection; Disease Progression; Disease-Free Survival; Europe; Female; Follow-Up Studies; Humans; Lutetium; Male; Middle Aged; Neoplasm Recurrence, Local; Neuroendocrine Tumors; Octreotide; Odds Ratio; Organometallic Compounds; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Receptors, Peptide; Retrospective Studies; Treatment Outcome

2016
Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.
    International journal of radiation oncology, biology, physics, 2006, May-01, Volume: 65, Issue:1

    Topics: Adult; Aged; Female; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Receptors, Somatostatin; Tomography, X-Ray Computed

2006